Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice
Suguru Yamamoto(Niigata University), Valentina Kon, Tracy E. Hunley(Vanderbilt University), Masaru Motojima(Tokai University), Agnes B. Fogo(Vanderbilt University Medical Center), Yiqin Zuo(University of Miami), Sergio Fazio(Alzheimer's Association), MacRae F. Linton(Vanderbilt University), Patricia G. Yancey(Vanderbilt University Medical Center), Jovanovic B.I.(Vanderbilt University Medical Center), Iekuni Ichikawa(Vanderbilt University Medical Center)
Cited by 69
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Current Perspectives on Statins
|Circulation|2000|1.2k
Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection
|American Journal of Transplantation|2003|1.1k